Download
s00393-021-01001-7.pdf 2,01MB
WeightNameValue
1000 Titel
  • Myofasziitis unter Nivolumab-Therapie
1000 Titelzusatz
  • Myofasciitis under nivolumab treatment
1000 Autor/in
  1. Krusche, Martin |
  2. Schneider, U. |
  3. Geisler, C. |
  4. Keller, S. |
  5. Stenzel, W. |
  6. Ohrndorf, S. |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-22
1000 Erschienen in
1000 Quellenangabe
  • 80(9):884-888
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00393-021-01001-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575749/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • We report the case of a 73-year-old female patient with malignant melanoma who developed rapidly progressive dermatosclerosis of the arms and legs as well as myalgia and flexion contractures during treatment with the immune checkpoint inhibitor nivolumab. The diagnosis of a myofasciitis was confirmed by imaging and biopsy. Following consultation with the treating dermato-oncologists nivolumab treatment was paused and treatment with methotrexate and prednisolone was initiated. Immune checkpoint inhibitors can induce a variety of immune-mediated side effects and can also imitate symptoms of rheumatological diseases. The occurrence of myofasciitis under immune checkpoint inhibition has been reported in the literature only in a few cases. Further oncological and rheumatological treatment management should be carried out in close interdisciplinary coordination.
1000 Sacherschließung
lokal Female [MeSH]
lokal Checkpointinhibitoren
lokal Checkpoint inhibitors
lokal Aged [MeSH]
lokal Drug-Related Side Effects and Adverse Reactions [MeSH]
lokal Myalgia contraction myositis
lokal Humans [MeSH]
lokal Fasziitis
lokal Nivolumab/adverse effects [MeSH]
lokal Eosinophilia
lokal Myalgie-Kontraktur-Myositis
lokal IrAEs
lokal Myalgia [MeSH]
lokal Fasciitis
lokal Kasuistiken
lokal Eosinophilie
lokal Myositis/diagnosis [MeSH]
lokal Melanoma/drug therapy [MeSH]
lokal Myositis/chemically induced [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-0582-7790|https://frl.publisso.de/adhoc/uri/U2NobmVpZGVyLCBVLg==|https://frl.publisso.de/adhoc/uri/R2Vpc2xlciwgQy4=|https://frl.publisso.de/adhoc/uri/S2VsbGVyLCBTLg==|https://frl.publisso.de/adhoc/uri/U3RlbnplbCwgVy4=|https://frl.publisso.de/adhoc/uri/T2hybmRvcmYsIFMu
1000 Hinweis
  • DeepGreen-ID: 185b3dcb4e47449fb5f03debd9d939d6 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
  1. Myofasziitis unter Nivolumab-Therapie
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450820.rdf
1000 Erstellt am 2023-05-11T11:09:31.338+0200
1000 Erstellt von 322
1000 beschreibt frl:6450820
1000 Zuletzt bearbeitet Fri Oct 20 10:23:58 CEST 2023
1000 Objekt bearb. Fri Oct 20 10:23:58 CEST 2023
1000 Vgl. frl:6450820
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450820 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source